These are valuable exercises, but a retirement plan with a 10% chance of failure looks a lot better in a spreadsheet than it sounds in real life. The problem is that if it goes wrong, there is no - I ...
Nissan Motor stock rose 15.8% in the most recent week. The no-moat company has gained 21.9% over the past three months and is ...
For 2025, bond investors might want to make themselves comfortable with where yields have been in 2024. The US economy is ...
The Institute for Supply Management releases its Chicago Business Barometer for December. Consensus estimate is for a 42.8 reading, 2.6 points more than in November. The National Association of ...
In the Need to Know column on Christmas Eve, Barbara Kollmeyer shared insights from strategists at Evercore ISI led by Julian Emanuel, who considered year-end selling action and corporate financial ...
Netflix has certainly done its share to promote the second season: It not only gave it a prime holiday spot on the calendar - it debuted the day after Christmas - but it also has created a free mobile ...
The S&P MERVAL Index is up 109983.70 points or 4.46% this week to 2577545.67 --Largest three-week percentage gain since the week ending Nov. 22, 2024 ...
PitchBook’s VC-Backed IPO Index is up 68% through Dec. 27 and at its highest level in three years. Utility-scale solar and battery storage installations are poised to set records in 2024, but policy ...
CoinDesk Bitcoin Price Index is down $1005.88 today or 1.05% to $94448.28 --Worst two day stretch since the two days ending Dec. 19, 2024, when it fell 9.8% --Down 2.66% month-to-date; On pace for ...
PitchBook’s VC-Backed IPO Index is up 68% through Dec. 27 and at its highest level in three years. Utility-scale solar and battery storage installations are poised to set records in 2024, but policy ...
The latest dispute is over immigration, and whether Trump should side with technology moguls like Tesla (TSLA) CEO Elon Musk, who have argued that the U.S. should be allowing in more immigrants, not ...
Bristol Myers Squibb received approval from the Food and Drug Administration for its treatment of certain cancers.